TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial.

Suzanne L Topalian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.